Novyra Pharmachem Limited intimates BSE of its board meeting scheduled for April 18, 2026.
Board to consider approval of audited financial results for Q4 and FY ended March 31, 2026.
Trading window for company securities closed from April 1, 2026, until 48 hours after results declaration.